Umbrella study of precise medical treatment in advanced lung cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027582

Enrollment

Unknown

Registered

2019-11-19

Start date

2016-05-18

Completion date

Unknown

Last updated

2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Case series:Not applicable

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed metastastic lung cancer; 2. With available sample(blood/tisse) for NGS genetic testing; or available freezing tumor tissue or other biological sample for genetic testing; 3. Signed the informed consent form; 4. With complete clinical information.

Exclusion criteria

Exclusion criteria: Without available sample(blood/tisse) for NGS genetic testing; or unavailable freezing tumor tissue or other biological sample for genetic testing.

Design outcomes

Primary

Measure	Time frame
Overall survival;	—

Countries

China

Contacts

Public ContactZhang Li

Sun Yat-Sen University Cancer Center

zhangli@sysucc.org.cn+86 020 87343822

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026